Your browser doesn't support javascript.
loading
The role of uromodulin in cardiovascular disease: a review.
Chen, Chengqian; Zhong, Wentao; Zheng, Hao; Dai, Gaoying; Zhao, Wei; Wang, Yushi; Dong, Qi; Shen, Botao.
Afiliación
  • Chen C; Department of Cardiology Center, The First Hospital of Jilin University, Changchun, China.
  • Zhong W; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
  • Zheng H; Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, China.
  • Dai G; Department of Cardiology Center, The First Hospital of Jilin University, Changchun, China.
  • Zhao W; Department of Cardiology Center, The First Hospital of Jilin University, Changchun, China.
  • Wang Y; Department of Cardiology Center, The First Hospital of Jilin University, Changchun, China.
  • Dong Q; Department of Cardiology Center, The First Hospital of Jilin University, Changchun, China.
  • Shen B; Department of Cardiology Center, The First Hospital of Jilin University, Changchun, China.
Front Cardiovasc Med ; 11: 1417593, 2024.
Article en En | MEDLINE | ID: mdl-39049957
ABSTRACT
Uromodulin, also referred to as Tamm Horsfall protein (THP), is a renal protein exclusively synthesized by the kidneys and represents the predominant urinary protein under normal physiological conditions. It assumes a pivotal role within the renal system, contributing not only to ion transport and immune modulation but also serving as a critical factor in the prevention of urinary tract infections and kidney stone formation. Emerging evidence indicates that uromodulin may serve as a potential biomarker extending beyond renal function. Recent clinical investigations and Mendelian randomization studies have unveiled a discernible association between urinary regulatory protein levels and cardiovascular events and mortality. This review primarily delineates the intricate relationship between uromodulin and cardiovascular disease, elucidates its predictive utility as a novel biomarker for cardiovascular events, and delves into its involvement in various physiological and pathophysiological facets of the cardiovascular system, incorporating recent advancements in corresponding genetics.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cardiovasc Med Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cardiovasc Med Año: 2024 Tipo del documento: Article País de afiliación: China